Clinical Report: Reoperative Urethroplasty for Recurrent Urethral Strictures in Men

Overview

Reoperative urethroplasty offers a high success rate ranging from 67% to 92% for treating recurrent urethral strictures, outperforming direct vision internal urethrotomy (DVIU) which has failure rates up to 100%. Despite excellent early outcomes with primary urethroplasty, 14–42% of patients experience recurrence requiring further intervention. This review highlights the variability in treatment approaches and the need for standardized guidelines.

Background

Urethral strictures are commonly managed with open reconstructive urethroplasty, which shows early success rates between 79% and 95%. However, a significant proportion of patients develop recurrent strictures necessitating additional treatment. Treatment options for recurrence include redo-urethroplasty and DVIU, with the latter favored for its minimally invasive nature but limited by high failure and complication rates. The complexity of recurrent strictures, often associated with scarring and poor vascularity, poses challenges for reconstructive surgeons, and there is a lack of consensus on optimal management strategies.

Data Highlights

A systematic review identified 39 relevant studies analyzing redo-urethroplasty techniques and outcomes. Primary success rates for redo-urethroplasty ranged from 67% to 92%, whereas DVIU failure rates could reach 100%. The review included data on stricture location, length, previous treatments, and complication rates, although detailed numerical data were not provided in the summary.

Key Findings

• Redo-urethroplasty demonstrates superior success rates (67–92%) compared to DVIU, which has high failure rates up to 100% in recurrent strictures.
• DVIU is primarily used for short (<1 cm) or bulbar recurrent strictures and in patients unsuitable for open surgery due to comorbidities or age.
• Repeated endoscopic treatments may lead to chronic strictures requiring lifelong management with self-dilatation and redo procedures.
• Prior endoscopic treatment is an independent risk factor for urethroplasty failure, likely due to increased scarring and tissue damage.
• There is considerable variation in clinical practice and a lack of standardized guidelines for managing recurrent urethral strictures after primary urethroplasty.
• Follow-up methods and patient-reported outcomes vary, with limited data on quality of life post-redo-urethroplasty.

Clinical Implications

Clinicians should consider redo-urethroplasty as the preferred treatment for recurrent urethral strictures due to its higher success rates compared to DVIU. Patient selection is critical, with DVIU reserved for short strictures or patients unfit for open surgery. Awareness of the increased risk of failure following prior endoscopic treatments should inform surgical planning. Standardized protocols and follow-up strategies are needed to optimize outcomes and patient quality of life.

Conclusion

Reoperative urethroplasty is an effective and durable option for managing recurrent urethral strictures, outperforming endoscopic methods in success rates. The complexity of recurrent strictures necessitates individualized treatment approaches and further research to establish standardized guidelines.

References

1. 1 -- Early success rates of urethroplasty
2. 2 -- Long-term recurrence rates after urethroplasty
3. 3 -- Variability in treatment practices for recurrent strictures
4. 4,5 -- Limitations and complications of DVIU
5. 6 -- Chronic urethral stricture management after repeated endoscopic treatment
6. 7 -- Variation in treatment approaches across organizations
7. 8 -- Prior endoscopic treatment as risk factor for urethroplasty failure
8. 9 -- PRISMA guidelines for systematic reviews
9. 10 -- Quality Appraisal of Case Series Studies Checklist